Open Access Open Access  Restricted Access Subscription Access

Drug Prescription Analysis at Hospital Discharge for Heart Failure Patients at the Institute of Cardiology of Abidjan


Affiliations
1 Medicine Department, Institute of Cardiology of Abidjan, Abidjan, Côte d'Ivoire
 

Introduction: Understanding improvement of pathophysiology of heart failure has allowed therapeutic progress over the past two decades in the pathology management. Our patients should benefit from these new drugs that improve survival. Objective: To analyze the treatment of hospital discharge according to ESC (European Society of Cardiology) Guidelines. Methods: We carried out a retrospective and descriptive study which included completed survey of patients hospitalized for heart failure in Medicine Department of cardiology Institut of Abidjan between January 1st 2011 to December 31st 2012. We analyzed the drugs prescription during hospital discharge by using the register of hospitalization. Results: 92.9% of the 532 files retained were included. Patients had a mean age of 54.4 ± 16.4 years old. 36.3% of the cases had a heart failure history with an average of 5.7 ± 3.2 days of hospital stay. At the hospital discharge, patients had for prescription: a diuretic specially Furosemide (100%), angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blockers (ARB) (63.7%), a beta-blocker (17.9%) and a mineralocorticoids receptor antagonist (MRA) (51.2%). Diuretic, IEC or ARB and the MRA were prescribed systematically. Beta-blockers were lower prescribed to patients who showed no more signs of congestion. Conclusion: Our prescribing practices were adapted to the guidelines for heart failure management. However, the gaps will be corrected through sensitization and training.

Keywords

Heart Failure, Prescription, Hospitalization, Discharge, Beta-Blockers.
User
Notifications
Font Size

Abstract Views: 140

PDF Views: 0




  • Drug Prescription Analysis at Hospital Discharge for Heart Failure Patients at the Institute of Cardiology of Abidjan

Abstract Views: 140  |  PDF Views: 0

Authors

Bamba-Kamagate Djenamba
Medicine Department, Institute of Cardiology of Abidjan, Abidjan, Côte d'Ivoire
Iklo Coulibaly
Medicine Department, Institute of Cardiology of Abidjan, Abidjan, Côte d'Ivoire
Esaie Soya
Medicine Department, Institute of Cardiology of Abidjan, Abidjan, Côte d'Ivoire
Fatoumata Traore
Medicine Department, Institute of Cardiology of Abidjan, Abidjan, Côte d'Ivoire
Marie-Paule N'Choh-Mattoh
Medicine Department, Institute of Cardiology of Abidjan, Abidjan, Côte d'Ivoire
Florent Koffi
Medicine Department, Institute of Cardiology of Abidjan, Abidjan, Côte d'Ivoire
Micesse Tanoh
Medicine Department, Institute of Cardiology of Abidjan, Abidjan, Côte d'Ivoire

Abstract


Introduction: Understanding improvement of pathophysiology of heart failure has allowed therapeutic progress over the past two decades in the pathology management. Our patients should benefit from these new drugs that improve survival. Objective: To analyze the treatment of hospital discharge according to ESC (European Society of Cardiology) Guidelines. Methods: We carried out a retrospective and descriptive study which included completed survey of patients hospitalized for heart failure in Medicine Department of cardiology Institut of Abidjan between January 1st 2011 to December 31st 2012. We analyzed the drugs prescription during hospital discharge by using the register of hospitalization. Results: 92.9% of the 532 files retained were included. Patients had a mean age of 54.4 ± 16.4 years old. 36.3% of the cases had a heart failure history with an average of 5.7 ± 3.2 days of hospital stay. At the hospital discharge, patients had for prescription: a diuretic specially Furosemide (100%), angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blockers (ARB) (63.7%), a beta-blocker (17.9%) and a mineralocorticoids receptor antagonist (MRA) (51.2%). Diuretic, IEC or ARB and the MRA were prescribed systematically. Beta-blockers were lower prescribed to patients who showed no more signs of congestion. Conclusion: Our prescribing practices were adapted to the guidelines for heart failure management. However, the gaps will be corrected through sensitization and training.

Keywords


Heart Failure, Prescription, Hospitalization, Discharge, Beta-Blockers.